Cancer Research The Future of Cancer Research: Science and Patient Impact  Cancer Health Disparities Conference 2009
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 48, 6943-6950, December 1, 1988]
© 1988 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Issandou, M.
Right arrow Articles by Darbon, J.-M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Issandou, M.
Right arrow Articles by Darbon, J.-M.

Inhibition of MCF-7 Cell Growth by 12-O-Tetradecanoylphorbol-13-acetate and 1,2-Dioctanoyl-sn-glycerol: Distinct Effects on Protein Kinase C Activity1

Marc Issandou, Francis Bayard and Jean-Marie Darbon2

Institut National de la Santé et de la Recherche Médicale, U 168, Department of Endocrinology, CHU Rangueil, Université Paul Sabatier, 31054 Toulouse Cedex, France

We have investigated the effects of phorbol ester 12-O-tetradecanoyl-phorbol-13-acetate (TPA) and permeant diacylglycerol 1,2-dioctanoyl-sn-glycerol (DiC8) on MCF-7 cell proliferation and protein kinase C activity. DiC8 mimics the effects of TPA on both cell morphology and proliferation, with an ED50 value of 11 µg/ml for cell growth inhibition. As with TPA and phorobol 12,13-dibutyrate, DiC8 enhances the degree of phosphorylation of an endogenous Mr 28,000 protein in a time- and dose-dependent manner. The effect is measurable upon 5 min of cell treatment with each protein kinase C activator and reaches a maximum at 30 min. The ED50s observed are 5 ng/ml and 20 µg/ml, respectively, for phorbol esters and DiC8. The Mr 28,000 protein is found in the cytosolic fraction and is phosphorylated on serine residues by both TPA and DiC8. Further characterization of the phosphorylated proteins using a highly resolutive two-dimensional electrophoresis demonstrates that the two-protein kinase C activators lead to slightly distinct protein phosphorylation patterns with an extra set of proteins phosphorylated under TPA but not DiC8 stimulation. Contrary to TPA, DiC8 induces only a partial and transient translocation of protein kinase C activity from the cytosolic to the particulate compartment. Moreover, no down-regulation of protein kinase C is observed after prolonged treatment of MCF-7 cells with DiC8, while only 10% of the initial protein kinase C level remains present in cells treated with TPA for 48 h. However, this remainder enzymatic activity is sufficient to induce the phosphorylation of the Mr 28,000 protein at its maximal level.

In conclusion, our results reinforce the hypothesis of a negative modulatory role of protein kinase C in MCF-7 cell proliferation but suggest that the two activators TPA and DiC8 could induce distinct molecular events with regard to the enzyme recruitment and activity as well as to its further processing.

1 Supported by Institut National de la Santé et de la Recherche Médicale and by Association de la Recherce contre le Cancer.

2 To whom requests for reprints should be addressed.

Received 4/25/88. Revised 8/11/88. Accepted 9/ 1/88.




This article has been cited by other articles:


Home page
CarcinogenesisHome page
M. Guo and J. J. Reiners Jr
Phorbol ester-induced production of cytostatic factors by normal and oncogenic Ha-ras-transformed human breast cell lines
Carcinogenesis, July 1, 2000; 21(7): 1303 - 1312.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
J.-J. Li, L. W. Oberley, M. Fan, and N. H. Colburn
Inhibition of AP-1 and NF-{kappa}B by manganese-containing superoxide dismutase in human breast cancer cells
FASEB J, December 1, 1998; 12(15): 1713 - 1723.
[Abstract] [Full Text]


Home page
J. Cell Sci.Home page
M. J. Clemens, I. Trayner, and J. Menaya
The role of protein kinase C isoenzymes in the regulation of cell proliferation and differentiation
J. Cell Sci., December 1, 1992; 103(4): 881 - 887.
[PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1988 by the American Association for Cancer Research.